These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 24973628

  • 1. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.
    Kamboj M, Xiao K, Kaltsas A, Huang YT, Sun J, Chung D, Wu S, Sheahan A, Sepkowitz K, Jakubowski AA, Papanicolaou G.
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628
    [Abstract] [Full Text] [Related]

  • 2. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L, Porcher R, Lafaurie M, Casin I, Robin M, Xhaard A, Andreoli AL, Rodriguez-Otero P, Dhedin N, Socié G, Ribaud P, Peffault de Latour R.
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [Abstract] [Full Text] [Related]

  • 3. Clostridium difficile infection in the hematopoietic unit: a meta-analysis of published studies.
    Zacharioudakis IM, Ziakas PD, Mylonakis E.
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1650-4. PubMed ID: 24914822
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
    Alonso CD, Treadway SB, Hanna DB, Huff CA, Neofytos D, Carroll KC, Marr KA.
    Clin Infect Dis; 2012 Apr; 54(8):1053-63. PubMed ID: 22412059
    [Abstract] [Full Text] [Related]

  • 5. Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
    Ganetsky A, Han JH, Hughes ME, Babushok DV, Frey NV, Gill SI, Hexner EO, Loren AW, Luger SM, Mangan JK, Martin ME, Smith J, Freyer CW, Gilmar C, Schuster M, Stadtmauer EA, Porter DL.
    Clin Infect Dis; 2019 May 30; 68(12):2003-2009. PubMed ID: 30256954
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
    Scardina TL, Kang Martinez E, Balasubramanian N, Fox-Geiman M, Smith SE, Parada JP.
    Pharmacotherapy; 2017 Apr 30; 37(4):420-428. PubMed ID: 28226419
    [Abstract] [Full Text] [Related]

  • 7. Effective treatment of Clostridioides difficile infection improves survival and affects graft-versus-host disease: a multicenter study by the Polish Adult Leukemia Group.
    Piekarska A, Sadowska-Klasa A, Mensah-Glanowska P, Sobczyk-Kruszelnicka M, Drozd-Sokołowska J, Waszczuk-Gajda A, Kujawska J, Wilk M, Tomaszewska A, Zaucha JM, Giebel S, Gil L.
    Sci Rep; 2024 Mar 11; 14(1):5947. PubMed ID: 38467719
    [Abstract] [Full Text] [Related]

  • 8. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
    Morrisette T, Van Matre AG, Miller MA, Mueller SW, Bajrovic V, Abidi MZ, Benamu E, Kaiser JN, Barber GR, Chase S, Tobin J, Fish DN, Gutman JA.
    Biol Blood Marrow Transplant; 2019 Oct 11; 25(10):2091-2097. PubMed ID: 31255741
    [Abstract] [Full Text] [Related]

  • 9. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Jabr R, El Atrouni W, Shune L, Telfah M, Gao G, He J, Abhyankar S, McGuirk J, Clough L.
    Transplant Cell Ther; 2021 Feb 11; 27(2):176.e1-176.e8. PubMed ID: 33830032
    [Abstract] [Full Text] [Related]

  • 10. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.
    Kinnebrew MA, Lee YJ, Jenq RR, Lipuma L, Littmann ER, Gobourne A, No D, van den Brink M, Pamer EG, Taur Y.
    PLoS One; 2014 Feb 11; 9(3):e90158. PubMed ID: 24662889
    [Abstract] [Full Text] [Related]

  • 11. Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplant.
    Agha A, Sehgal A, Lim MJ, Weber D, Hou JZ, Farah R, Raptis A, Im A, Dorritie K, Marks S, Agha M, Lim SH.
    Am J Hematol; 2016 Mar 11; 91(3):291-4. PubMed ID: 26661725
    [Abstract] [Full Text] [Related]

  • 12. Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant.
    Prohaska L, Mahmoudjafari Z, Shune L, Singh A, Lin T, Abhyankar S, Ganguly S, Grauer D, McGuirk J, Clough L.
    Hematol Oncol Stem Cell Ther; 2018 Dec 11; 11(4):233-240. PubMed ID: 29928848
    [Abstract] [Full Text] [Related]

  • 13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 11; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 14. Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation.
    Salamonowicz M, Ociepa T, Frączkiewicz J, Szmydki-Baran A, Matysiak M, Czyżewski K, Wysocki M, Gałązka P, Zalas-Więcek P, Irga-Jaworska N, Drożyńska E, Zając-Spychała O, Wachowiak J, Gryniewicz-Kwiatkowska O, Czajńska-Deptuła A, Dembowska-Bagińska B, Chełmecka-Wiktorczyk L, Balwierz W, Bartnik M, Zielezińska K, Urasiński T, Tomaszewska R, Szczepański T, Płonowski M, Krawczuk-Rybak M, Pierlejewski F, Młynarski W, Gamrot-Pyka Z, Woszczyk M, Małas Z, Badowska W, Urbanek-Dądela A, Karolczyk G, Stolpa W, Sobol-Milejska G, Zaucha-Prażmo A, Kowalczyk J, Goździk J, Gorczyńska E, Jermakow K, Król A, Chybicka A, Ussowicz M, Kałwak K, Styczyński J.
    Eur J Clin Microbiol Infect Dis; 2018 Sep 11; 37(9):1805-1812. PubMed ID: 29978303
    [Abstract] [Full Text] [Related]

  • 15. Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis.
    Alonso CD, Marr KA.
    Curr Opin Infect Dis; 2013 Aug 11; 26(4):326-31. PubMed ID: 23806895
    [Abstract] [Full Text] [Related]

  • 16. Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
    Blumberg EA, Collins G, Young JH, Nguyen MH, Michonneau D, Temesgen Z, Origȕen J, Barcan L, Obeid KM, Belloso WH, Gras J, Corbelli GM, Neaton JD, Lundgren J, Snydman DR, Molina JM, INSIGHT Clostridioides difficile Study Group.
    Transpl Infect Dis; 2022 Feb 11; 24(1):e13770. PubMed ID: 34821423
    [Abstract] [Full Text] [Related]

  • 17. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T, Labuszewski L, Pacheco SM, Adams W, Schreckenberger P, Johnson S.
    Infect Control Hosp Epidemiol; 2015 Mar 11; 36(3):280-6. PubMed ID: 25695169
    [Abstract] [Full Text] [Related]

  • 18. Clostridium difficile: deleterious impact on hematopoietic stem cell transplantation.
    Callejas-Díaz A, Gea-Banacloche JC.
    Curr Hematol Malig Rep; 2014 Mar 11; 9(1):85-90. PubMed ID: 24390550
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada.
    Lavallée C, Labbé AC, Talbot JD, Alonso CD, Marr KA, Cohen S, Laverdière M, Dufresne SF.
    Transpl Infect Dis; 2017 Feb 11; 19(1):. PubMed ID: 27943498
    [Abstract] [Full Text] [Related]

  • 20. Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation.
    Weber S, Scheich S, Magh A, Wolf S, Enßle JC, Brunnberg U, Reinheimer C, Wichelhaus TA, Kempf VAJ, Kessel J, Vehreschild MJGT, Serve H, Bug G, Steffen B, Hogardt M.
    Int J Infect Dis; 2020 Oct 11; 99():428-436. PubMed ID: 32798661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.